Stem cell innovation at risk in UK: studies

Despite great hopes for stem cell therapy, major structural and cultural changes within the NHS are needed if it is to succeed in the UK. Currently the chances of getting effective treatments into routine use in the short-term are small and the industry is at serious risk of 'market failure'.

If you want to include this story in your blog, copy and paste this formatted text: